Science Daily - Heart Disease
MAY 8, 2024
Experts released a new clinical guideline for effectively managing individuals diagnosed with hypertrophic cardiomyopathy (HCM). The guideline reiterates the importance of collaborative decision-making with patients who have HCM and provides updated recommendations for the most effective treatment pathways for adult and pediatric patients.
Med Page Today
MAY 8, 2024
(MedPage Today) -- A mobile app used with an insulin pump that led to 224 injuries was recalled by Tandem Diabetes Care, the FDA announced today. The recall is for the 2.7 version of the Apple iOS t:connect mobile app, used in conjunction with.
CardiacWire
MAY 8, 2024
A new JAMA study revealed that a shocking 90% of US adults are at risk of developing cardiovascular-kidney-metabolic (CKM) syndrome, underscoring the need for preventative action before we face a wave of CKM-related heart disease. Officially published by the AHA six months ago, CKM syndrome defines the connections and risks associated with obesity, type 2 diabetes, chronic kidney disease, and cardiovascular disease.
DAIC
MAY 8, 2024
Feinstein Institutes’ Dr. Stavros Zanos is the senior author on the new bioelectronic medicine ultrasound paper. (Credit: Feinstein Institutes) milla1cf Wed, 05/08/2024 - 10:57 May 8, 2024 — Ultrasound could one day complement or even replace drugs to treat diseases. Bioelectronic medicine scientists at The Feinstein Institutes for Medical Research used noninvasive, splenic focused ultrasound stimulation (sFUS) and found they can reduce inflammation and improve symptoms of pulmonary arter
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Med Page Today
MAY 8, 2024
(MedPage Today) -- Updates to national guidelines for the management of hypertrophic cardiomyopathy (HCM) endorse cardiac myosin inhibitor use in certain cases, greenlight more intensive physical activity, and expand treatment options for young.
DAIC
MAY 8, 2024
63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients milla1cf Wed, 05/08/2024 - 11:12 May 8, 2024 — In a groundbreaking development, a study published in the Journal of Vascular Surgery reveals for the first time that coronary CTA ( CCTA ) with fractional flow reserve (FFR CT ) care significantly reduces mortality by over 60 percent at five years in patients with PAD undergoing major vascular surgery, far surpassing the current standard of care. 1 Atherosclerosis is a systemic
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
DAIC
MAY 8, 2024
milla1cf Wed, 05/08/2024 - 11:02 May 8, 2024 — 4C Medical Technologies, Inc. ("4C Medical"), a medical device company dedicated to advancing minimally invasive therapies for structural heart disease, has been granted Breakthrough Device designation by the U.S. Food and Drug Administratio n ( FDA ) for the AltaValve System , a transcatheter mitral valve replacement (TMVR) device.
HCPLive
MAY 8, 2024
Nicole Chase, MD; S Shahzad Mustafa, MD; Sande Okelo, MD, and Robert Sporter, MD, examine the distinct manifestations of asthma stemming from allergic and non-allergic origins, as well as the factors contributing to its exacerbation.
DAIC
MAY 8, 2024
mtaschetta-millane Wed, 05/08/2024 - 15:21 May 8, 2024 — The US Food and Drug Administration ( FDA ) is alerting health care providers and facilities about our continued safety and quality concerns with the following Getinge/Maquet cardiovascular medical devices: Getinge/Maquet/Datascope Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pump (IABP) devices and Getinge/Maquet Cardiohelp system and HLS Sets.
Open Heart
MAY 8, 2024
Objective Implantable loop recorders (ILRs) are increasingly used for long-term rhythm monitoring after ischaemic and cryptogenic stroke, with the goal of detecting atrial fibrillation (AF) and subsequent initiation of oral anticoagulation to reduce risk of adverse clinical outcomes. There is a need to determine the effectiveness of different rhythm monitoring strategies in this context.
NEJM Journal Watch - Cardiology
MAY 8, 2024
A large observational study suggests additive effects on clinical outcomes.
Becker's Hospital Review - Cardiology
MAY 8, 2024
Utica, N.Y.-based Wynn Hospital is temporarily suspending open-heart surgeries to review and strengthen the service, NBC affiliate WKTV reported May 7.
American College of Cardiology
MAY 8, 2024
The following are key points to remember from a state-of-the-art review on aspirin hypersensitivity. This guide offers a practical approach to distinguishing and managing different types of aspirin reactions and highlights the role of interdisciplinary collaboration.
HCPLive
MAY 8, 2024
Daniel Su, MD describes the promise of APX3330 for delaying or preventing diabetic retinopathy progression in a post-hoc analysis of the ZETA-1 trial.
American College of Cardiology
MAY 8, 2024
The newest clinical guideline, released May 8 by the ACC and the American Heart Association (AHA), provides the latest evidence-based recommendations for effectively managing individuals diagnosed with hypertrophic cardiomyopathy (HCM).
HCPLive
MAY 8, 2024
These findings can be used to enhance usability of the digital health app and improve outcomes and quality of life among patients with long COVID.
American College of Cardiology
MAY 8, 2024
The following are key points to remember from the 2024 AHA/ACC/multisociety guideline for the management of hypertrophic cardiomyopathy (HCM).
HCPLive
MAY 8, 2024
A new study highlights the potential of lipoprotein apheresis for reducing cardiovascular events in patients with elevated Lp(a).
American Heart News - Heart News
MAY 8, 2024
WASHINGTON and DALLAS (May 8, 2024) – The American College of Cardiology (ACC) and the American Heart Association (AHA) today released a new clinical guideline for effectively managing individuals diagnosed with hypertrophic cardiomyopathy (HCM). The.
ADN Center of Excellence
MAY 8, 2024
As medical professionals dedicated to the pursuit of excellence in patient care and medical knowledge, the significance of continuous learning cannot be overstated. In the ever-evolving landscape of healthcare, staying abreast of the latest advancements, techniques, and technologies is not just beneficial but essential. One crucial aspect of this ongoing educational journey is hands-on training, a cornerstone in the development and refinement of clinical skills.
Cardiovascular Diabetology
MAY 8, 2024
The triglyceride glucose-body mass index (TyG-BMI) is recognized as a reliable surrogate for evaluating insulin resistance and an effective predictor of cardiovascular disease. However, the link between TyG-BM.
HCPLive
MAY 8, 2024
An IMID diagnosis or use of immunomodulatory medications were not shown to be a significant risk factor of severe COVID-19 outcomes.
ADN Center of Excellence
MAY 8, 2024
As medical professionals dedicated to the pursuit of excellence in patient care and medical knowledge, the significance of continuous learning cannot be overstated. In the ever-evolving landscape of healthcare, staying abreast of the latest advancements, techniques, and technologies is not just beneficial but essential. One crucial aspect of this ongoing educational journey is hands-on training, a cornerstone in the development and refinement of clinical skills.
HCPLive
MAY 8, 2024
These data from investigators at Trinity College Dublin highlighted the immune response mechanisms visible in children with atopic dermatitis.
Cardiovascular Diabetology
MAY 8, 2024
Sepsis is a severe form of systemic inflammatory response syndrome that is caused by infection. Sepsis is characterized by a marked state of stress, which manifests as nonspecific physiological and metabolic c.
HCPLive
MAY 8, 2024
In an interview with HCPLive, Karlin discussed the unmet need for GAD screening.
Cardiovascular Diabetology
MAY 8, 2024
Dynamin-related protein 1 (Drp1) is a crucial regulator of mitochondrial dynamics, the overactivation of which can lead to cardiovascular disease. Multiple distinct posttranscriptional modifications of Drp1 have been reported, among which S-nitrosylation was recently introduced. However, the detailed regulatory mechanism of S-nitrosylation of Drp1 (SNO-Drp1) in cardiac microvascular dysfunction in diabetes remains elusive.
HCPLive
MAY 8, 2024
Findings suggest the potential prognostic value of time-averaged serum uric acid for predicting disease progression in IgAN.
Frontiers in Cardiovascular Medicine
MAY 8, 2024
Patients with pulmonary hypertension associated with a left-right shunt include a wide spectrum of pathophysiological substrates, ranging from those characterized by pulmonary over-circulation to those with advanced pulmonary vascular disease. The former group may benefit from shunt repair in carefully selected cases but, when advanced pulmonary vascular disease has developed, defect closure should be avoided, and pulmonary vasodilators may be used to improve effort tolerance and hemodynamics.
HCPLive
MAY 8, 2024
Findings suggest unstable housing may inhibit direct-acting antiviral treatment initiation in PWID with unstable housing compared to those with stable housing.
Frontiers in Cardiovascular Medicine
MAY 8, 2024
In high-risk patients with pure native aortic regurgitation (PNAR), transcatheter aortic valve replacement (TAVR) remains an off-label intervention. Due to anatomical variations in the aortic root and technical challenges unique to PNAR, the transfemoral approach (TF-TAVR) requires continued accumulation of experience and technological refinement. In this context, we successfully and safely performed a snare-assisted TF-TAVR procedure for a patient with PNAR, characterized by significant aortic
HCPLive
MAY 8, 2024
In an interview with HCPLive, Karlin and Robinson discuss the phase 2b trial on MM120 for generalized anxiety disorder.
Open Heart
MAY 8, 2024
Background Despite maximal treatment, heart failure (HF) remains a major clinical challenge. Besides neurohormonal overactivation, myocardial energy homoeostasis is also impaired in HF. Trimetazidine has the potential to restore myocardial energy status by inhibiting fatty acid oxidation, concomitantly enhancing glucose oxidation. Trimetazidine is an interesting adjunct treatment, for it is safe, easy to use and comes at a low cost.
HCPLive
MAY 8, 2024
Dolly Chang, MD, PhD, describes results from an exploratory analysis on the long-term impact of rapid fluid reduction on outcomes in DME.
AMS Cardiology
MAY 8, 2024
As we age, our bodies naturally start to change. This can include our hearts, which may develop conditions like bradycardia or a slow heart rate. While a slow heart rhythm might not sound concerning, it can sometimes lead to alarming symptoms and even pose severe health risks. What Is Bradycardia ? Are you wondering “ What is bradycardia ?” Bradycardia is a condition in which the heart’s rhythm is too slow.
HCPLive
MAY 8, 2024
Panelists discuss ongoing clinical trials aimed at lowering Lipoprotein(a) levels, emphasizing the importance of proactive patient testing, and referring to new guidelines recommending that everyone be tested once in their lifetime.
Expert insights. Personalized for you.
120 
Let's personalize your content